Literature DB >> 22373724

Etiologies and outcomes of acute liver failure in Germany.

Johannes Hadem1, Frank Tacke, Tony Bruns, Julia Langgartner, Pavel Strnad, Gerald U Denk, Panagiotis Fikatas, Michael P Manns, Wolf P Hofmann, Guido Gerken, Frank Grünhage, Andreas Umgelter, Christian Trautwein, Ali Canbay.   

Abstract

BACKGROUND & AIMS: Acute liver failure (ALF) is a severe form of acute liver injury that can progress to multiple organ failure. We investigated causes and outcomes of ALF.
METHODS: Eleven university medical centers in Germany were asked to report patients with (primary) severe acute liver injury (sALI) (international normalized ratio [INR] >1.5 but no hepatic encephalopathy) and primary ALF (INR >1.5 with overt hepatic encephalopathy) treated from 2008 to 2009. Data were analyzed from 46 patients with sALI and 109 patients with ALF.
RESULTS: The most frequent etiologies of primary ALF were non-acetaminophen drug-induced (32%), indeterminate (24%), and viral (21%); acetaminophen ingestion was the cause of ALF in only 9% of patients. The support of a ventilator was required by 44% of patients with ALF, vasopressors by 38%, and renal replacement by 36%. Seventy-nine patients with ALF (72%) survived until hospital discharge, 38 (35%) survived without emergency liver transplantation (ELT), and 51 received ELT (47%); 80% of patients who received ELT survived until discharge from the hospital.
CONCLUSIONS: In Germany, drug toxicity, indeterminate etiology, and viral hepatitis appear to be the major causes of primary ALF, which has high mortality. Patients with ALF are at great risk of progressing to multiple organ failure, but 80% of patients who receive ELT survive until discharge from the hospital.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22373724     DOI: 10.1016/j.cgh.2012.02.016

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  41 in total

Review 1.  Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.

Authors:  Shannan R Tujios; William M Lee
Journal:  Liver Int       Date:  2017-09-18       Impact factor: 5.828

Review 2.  Approach to clinical syndrome of jaundice and encephalopathy in tropics.

Authors:  Anil C Anand; Hitendra K Garg
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

Review 3.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

Review 4.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

Review 5.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

Review 6.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

7.  Pathological implications of cadherin zonation in mouse liver.

Authors:  Madlen Hempel; Annika Schmitz; Sandra Winkler; Ozlem Kucukoglu; Sandra Brückner; Carien Niessen; Bruno Christ
Journal:  Cell Mol Life Sci       Date:  2015-02-17       Impact factor: 9.261

Review 8.  [Extracorporeal therapies in hepatic diseases].

Authors:  D Jarczak; G Braun; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-08       Impact factor: 0.840

Review 9.  [Paracetamol. Efficacious and safe for all ages].

Authors:  M Wehling
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

Review 10.  Acute Fatty Liver of Pregnancy: Pathophysiology, Anesthetic Implications, and Obstetrical Management.

Authors:  Emily E Naoum; Lisa R Leffert; Hovig V Chitilian; Kathryn J Gray; Brian T Bateman
Journal:  Anesthesiology       Date:  2019-03       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.